BDBM660413 US20240092799, Compound XXVIII-L

SMILES CNC(=O)Nc1cc(Nc2nc3c(s2)C(=O)NC32CCCCC2)ncn1

InChI Key InChIKey=POAZHDPCSIADNI-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 660413   

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Hepagene Therapeutics (Hk

US Patent
LigandPNGBDBM660413(US20240092799, Compound XXVIII-L)
Affinity DataIC50: 5.5nMAssay Description:This protocol establishes the binding assays for MNK1 and MNK2 using ADP-Glo assay. MNK phosphorylates the substrate and converts ATP to ADP, which w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent